Active Ingredient: BENDAMUSTINE HYDROCHLORIDE
Proprietary Name: BENDAMUSTINE HYDROCHLORIDE
Dosage Form; Route of Administration: POWDER; IV (INFUSION)
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204104
Product Number: 002
Approval Date: Apr 28, 2023
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
